Adult Onset Langerhans Cell Histiocytosis: Clinical Characteristics and Treatment Outcomes.

Arslan Davulcu, Eren; Soyer, Nur; Demirci, Zühal; Günes, Ajda; Vural, Filiz; Sahin, Fahri; Töbü, Mahmut; Kamer, Serra; Hekimgil, Mine; Saydam, Güray

Arslan Davulcu, Eren; Soyer, Nur; Demirci, Zühal; Günes, Ajda; Vural, Filiz; Sahin, Fahri; Töbü, Mahmut; Kamer, Serra; Hekimgil, Mine; Saydam, Güray.

Afiliación

Arslan Davulcu E; University of Health Sciences Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Hematology Clinic, Zuhuratbaba Mah, Dr. Tevfik Saglam Cad No:11, Bakirköy, 34147, Istanbul, Turkey. erenarslan85@yahoo.com.
Soyer N; Faculty of Medicine, Hematology Department, Ege University, Izmir, Turkey.
Demirci Z; Faculty of Medicine, Hematology Department, Ege University, Izmir, Turkey.
Günes A; Faculty of Medicine, Hematology Department, Ege University, Izmir, Turkey.
Vural F; Faculty of Medicine, Hematology Department, Ege University, Izmir, Turkey.
Sahin F; Faculty of Medicine, Hematology Department, Ege University, Izmir, Turkey.
Töbü M; Faculty of Medicine, Hematology Department, Ege University, Izmir, Turkey.
Kamer S; Faculty of Medicine, Radiation Oncology Department, Ege University, Izmir, Turkey.
Hekimgil M; Faculty of Medicine, Pathology Department, Ege University, Izmir, Turkey.
Saydam G; Faculty of Medicine, Hematology Department, Ege University, Izmir, Turkey.

Clin Hematol Int ; 5(2-3): 101-106, 2023 Jun.

Article en En | MEDLINE | ID: mdl-36826750

Palabras clave

Cladribine; Histiocytic disorders; Langerhans cell histiocytosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Clin Hematol Int Año: 2023 Tipo del documento: Article País de afiliación: Turquía